BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pyne S, Adams DR, Pyne NJ. Sphingosine Kinases as Druggable Targets. In: Gomez-cambronero J, Frohman MA, editors. Lipid Signaling in Human Diseases. Cham: Springer International Publishing; 2020. pp. 49-76. [DOI: 10.1007/164_2018_96] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Squillace S, Spiegel S, Salvemini D. Targeting the Sphingosine-1-Phosphate Axis for Developing Non-narcotic Pain Therapeutics. Trends Pharmacol Sci 2020;41:851-67. [PMID: 33010954 DOI: 10.1016/j.tips.2020.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Blankenbach KV, Bruno G, Wondra E, Spohner AK, Aster NJ, Vienken H, Trautmann S, Ferreirós N, Wieland T, Bruni P, Meyer Zu Heringdorf D. The WD40 repeat protein, WDR36, orchestrates sphingosine kinase-1 recruitment and phospholipase C-β activation by Gq-coupled receptors. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158704. [PMID: 32244061 DOI: 10.1016/j.bbalip.2020.158704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim JL, Mestre B, Shin SH, Futerman AH. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid. Cell Signal 2021;82:109958. [PMID: 33607256 DOI: 10.1016/j.cellsig.2021.109958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Alsanafi M, Kelly SL, McNaughton M, Merrill AH Jr, Pyne NJ, Pyne S. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158631. [PMID: 31954175 DOI: 10.1016/j.bbalip.2020.158631] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Niazi H, Zoghdani N, Couty L, Leuci A, Nitzsche A, Allende ML, Mariko B, Ishaq R, Aslan Y, Becker PH, Gazit SL, Poirault-Chassac S, Decouture B, Baudrie V, De Candia E, Kono M, Benarab A, Gaussem P, Tharaux PL, Chun J, Provot S, Debili N, Therond P, Proia RL, Bachelot-Loza C, Camerer E. Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. Blood Adv 2019;3:1702-13. [PMID: 31171507 DOI: 10.1182/bloodadvances.2019031948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang G, Bieberich E. Sphingolipids in neurodegeneration (with focus on ceramide and S1P). Adv Biol Regul 2018;70:51-64. [PMID: 30287225 DOI: 10.1016/j.jbior.2018.09.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
7 Cartier A, Hla T. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science 2019;366:eaar5551. [PMID: 31624181 DOI: 10.1126/science.aar5551] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 49.5] [Reference Citation Analysis]
8 Blankenbach KV, Claas RF, Aster NJ, Spohner AK, Trautmann S, Ferreirós N, Black JL, Tesmer JJG, Offermanns S, Wieland T, Meyer Zu Heringdorf D. Dissecting Gq/11-Mediated Plasma Membrane Translocation of Sphingosine Kinase-1. Cells 2020;9:E2201. [PMID: 33003441 DOI: 10.3390/cells9102201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Grassi S, Mauri L, Prioni S, Cabitta L, Sonnino S, Prinetti A, Giussani P. Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases. Front Pharmacol 2019;10:807. [PMID: 31427962 DOI: 10.3389/fphar.2019.00807] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]